Matrix Asset Advisors Inc. NY Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
Matrix Asset Advisors Inc. NY lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 168.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,973 shares of the healthcare conglomerate’s stock after buying an additional 11,915 shares during the period. Matrix Asset Advisors Inc. NY’s holdings in UnitedHealth Group were worth $9,566,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Zullo Investment Group Inc. boosted its stake in shares of UnitedHealth Group by 0.7% in the 2nd quarter. Zullo Investment Group Inc. now owns 3,001 shares of the healthcare conglomerate’s stock worth $1,443,000 after buying an additional 20 shares during the last quarter. Northern Financial Advisors Inc lifted its position in UnitedHealth Group by 0.6% during the second quarter. Northern Financial Advisors Inc now owns 3,381 shares of the healthcare conglomerate’s stock valued at $1,625,000 after purchasing an additional 20 shares in the last quarter. Addison Advisors LLC lifted its position in UnitedHealth Group by 9.0% during the second quarter. Addison Advisors LLC now owns 241 shares of the healthcare conglomerate’s stock valued at $116,000 after purchasing an additional 20 shares in the last quarter. Elgethun Capital Management lifted its position in UnitedHealth Group by 0.3% during the second quarter. Elgethun Capital Management now owns 7,793 shares of the healthcare conglomerate’s stock valued at $3,746,000 after purchasing an additional 20 shares in the last quarter. Finally, Investmark Advisory Group LLC lifted its position in UnitedHealth Group by 2.6% during the second quarter. Investmark Advisory Group LLC now owns 776 shares of the healthcare conglomerate’s stock valued at $373,000 after purchasing an additional 20 shares in the last quarter. 85.69% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on UNH. Piper Sandler raised their price target on UnitedHealth Group from $580.00 to $584.00 and gave the company an “overweight” rating in a report on Monday, October 16th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Tuesday, November 21st. Truist Financial reissued a “buy” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Thursday, November 30th. Jefferies Financial Group decreased their price target on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating on the stock in a report on Monday, November 20th. Finally, Stephens reaffirmed an “overweight” rating and issued a $585.00 target price on shares of UnitedHealth Group in a report on Wednesday, December 13th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $574.89.
View Our Latest Analysis on UnitedHealth Group
Insider Activity at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 4,498 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares in the company, valued at $5,017,173.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the sale, the director now owns 635,528 shares in the company, valued at $349,788,255.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 4,498 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the transaction, the executive vice president now directly owns 9,218 shares of the company’s stock, valued at approximately $5,017,173.04. The disclosure for this sale can be found here. Over the last quarter, insiders sold 192,094 shares of company stock worth $104,507,072. Company insiders own 0.35% of the company’s stock.
UnitedHealth Group Trading Down 1.6 %
Shares of NYSE UNH opened at $515.90 on Thursday. The business’s 50 day moving average is $537.21 and its two-hundred day moving average is $507.32. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The stock has a market capitalization of $477.17 billion, a P/E ratio of 22.39, a PEG ratio of 1.59 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share for the quarter, topping the consensus estimate of $6.33 by $0.23. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The company had revenue of $92.36 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the previous year, the firm posted $5.79 earnings per share. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 24.95 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, December 4th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, December 1st. This represents a $7.52 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 32.64%.
UnitedHealth Group Company Profile (Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
NYSE: UNH” width=”650″ height=”350″ loading=”lazy”>
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and UnitedHealth Group wasn’t on the list.
While UnitedHealth Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s guide to pot stock investing and which pot companies show the most promise.